Trial | NCT00395551  Report issue

Title

Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.
A Single Center Study of the Safety and Efficacy of Multiple Intravitreal Injections of Ranibizumab in Subjects With CNV Secondary to Causes Other Than AMD.

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    30
The purpose of this study is to determine whether ranibizumab is effective in the treatment of choroidal neovascularization secondary to causes other then wet macular-degeneration.
Study Started
Dec 31
2005
Primary Completion
Jun 30
2009
Study Completion
Jun 30
2009
Last Update
Jan 08
2010
Estimate

Drug ranibizumab

0.5mg intravitreal injection

ranibizumab Active Comparator

ranibizumab 0.5mg intravitreal injection

Criteria 

Inclusion Criteria:

active choroidal neovascularization

Exclusion Criteria:

pregnancy,age-related macular degeneration, current eye infection or recent eye surgery, participating in other eye studies
No Results Posted